Highlights

Robust operating performance

• Fulfilling an essential role in combatting the COVID-19 pandemic
• Significant financial impact in April 2020 due to COVID-19 restrictions
• Rebound in trading from May 2020 onwards particularly at Hirslanden and Mediclinic Middle East
• Strong financial position and liquidity

Ongoing strategic execution

• Remaining focused on future growth through operational delivery and strategy execution
• Accelerating virtual care initiatives to address changing client needs
• Pursuing opportunities across the continuum of care

Outlook

• Cautious on impact of the pandemic and its economic aftermath on near-term performance
• Well positioned for long-term industry trends